Table 2.
Characteristics of patients.
| First author (year) | Number of pts | Etiology of liver disease | Sex (male/female) (n) | Age (mean) | Groups | Follow-up (days) | Overall response (n) | Complete response (n) | No response (n) | p |
|---|---|---|---|---|---|---|---|---|---|---|
| Sheng (2017) | 34 | NA | 36/32 | 36.90 | XBJ group | 7 | 31 | 16 | 3 | <0.05 |
| 34 | NA | Control group | 7 | 25 | 10 | 9 | ||||
|
| ||||||||||
| Yuan (2015) | 45 | NA | 36/9 | 53.50 | XBJ group | 10 | 40 | 25 | 5 | <0.05 |
| 40 | NA | 32/8 | 52.30 | Control group | 10 | 27 | 18 | 13 | ||
|
| ||||||||||
| Wang (2015) | 44 | NA | 23/21 | 37.85 | XBJ group | 7 | 40 | 27 | 4 | <0.05 |
| 44 | NA | 22/22 | 37.92 | Control group | 7 | 33 | 15 | 11 | ||
|
| ||||||||||
| Zhang (2014) | 32 | HBV 32 | 18/14 | 50.12 | XBJ group | 28 | 28 | 20 | 4 | <0.05 |
| 32 | 18/14 | 51.21 | Control group | 28 | 22 | 10 | 10 | |||
|
| ||||||||||
| Shu (2011) | 32 | HBV 49; HCV 7; alcohol 5; PBC 3; cryptogenic cirrhosis 2 |
54/12 | 33.92 | XBJ group | 14 | 28 | 10 | 4 | <0.05 |
| 34 | Control group | 14 | 24 | 8 | 10 | |||||
|
| ||||||||||
| Zhang (2010) | 90 | Posthepatitic cirrhosis 73; alcohol 9; PBC 5; cryptogenic cirrhosis 3 |
62/28 | 47.20 | XBJ group | 7 | 83 | 8 | 7 | <0.05 |
| 78 | Posthepatitic cirrhosis 67; alcohol 7; PBC 3; cryptogenic cirrhosis 1 |
61/17 | 48.10 | Control group | 7 | 63 | 2 | 15 | ||
|
| ||||||||||
| Wang (2010) | 30 | HBV 36; HCV 5; alcohol 14; PBC 2; unknown origin 3 |
47/13 | 51.38 | XBJ group | 7 | 28 | 20 | 2 | <0.05 |
| 30 | Control group | 7 | 21 | 14 | 9 | |||||
|
| ||||||||||
| Jing (2010) | 32 | NA | 23/9 | 49.30 | XBJ group | 7 | 29 | 22 | 3 | <0.05 |
| 28 | NA | 21/7 | 48.70 | Control group | 7 | 22 | 13 | 6 | ||
|
| ||||||||||
| Gao (2009) | 45 | NA | 38/7 | 48.30 | XBJ group | 10 | 35 | 25 | 10 | >0.05 |
| 40 | NA | 35/5 | 46.20 | Control group | 10 | 27 | 18 | 13 | ||
Pts, patients; XBJ, Xuebijing injection; HBV, hepatitis B virus; HCV, hepatitis C virus; PBC, primary biliary cirrhosis.